BBSRC Portfolio Analyser

BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Lutz Jermutus
Current InstitutionAstraZeneca UK Limited
Current DepartmentMedImmune Cambridge
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
BB/I016589/1 Directed evolution of therapeutic enzymes as alternatives to antibodies Co-investigator 91,932 Training Grants
terms and conditions of use (opens in new window)
export PDF file
back to list new search